Response to Gefitinib in Pericardial Effusion Due to Lung Cancer
We described a 70 years old patient with pericardial effusion due to adenocarcinoma of the lung, in whom gefitinib, which is an oral selective inhibitor of the epidermal growth factor receptor of tyrosine kinase, demonstrated a marked antitumor effect. We recommend possible consideration of a treatm...
Main Authors: | Norihiro Kikuchi, Hiroaki Satoh, Takahide Kodama, Norihiro Haraguchi, Kiyohisa Sekizawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2003-01-01
|
Series: | Acta Medica |
Subjects: | |
Online Access: | https://actamedica.lfhk.cuni.cz/46/4/0215/ |
Similar Items
-
PERICARDIAL EFFUSION IN HIV-INFECTED PATIENT
by: E. V. Filippov, et al.
Published: (2014-07-01) -
PERICARDIAL EFFUSION IN HIV-INFECTED PATIENT
by: E. V. Filippov, et al.
Published: (2014-07-01) -
Management of Massive Pericardial Effusion
by: Somchai Waikittipong
Published: (2013-08-01) -
Thymoma: A rare presentation as recurrent pericardial effusion
by: Dipesh Jha, et al.
Published: (2023-01-01) -
Pulsus paradoxus due to left ventricular collapse with localized pericardial effusion
by: Ali Çoner, et al.
Published: (2013-02-01)